Controlling Maternal Anemia and Malaria (June 2015)

The WHO 2012 updated policy on intermittent preventive treatment in pregnancy (IPTp) as well as the RBM Global Call to Action to Increase National Coverage of IPTp of Malaria in Pregnancy for Immediate Impact underscore the importance of increasing IPTp) and iron-folic acid (IFA) coverage to reduce maternal and child mortality.  Both documents promote WHO policy- urging program implementers to give pregnant women a dose of folic acid less than 5 mg per day to ensure the effectiveness of IPTp in saving the lives of mothers and their infants. Two new advocacy documents promote acceleration of IPTp uptake and anemia prevention during pregnancy and using a lower dose of folic acid that will ensure a reduction of both malaria and anemia in pregnancy.  These include:

1. Consensus Statement- “Roll Back Malaria Partnership- Malaria in Pregnancy Working Group Consensus Statement on Folic Acid Supplementation During Pregnancy”

2. Program Brief- “Controlling Maternal Anemia and Malaria: Ensuring Pregnant Women Receive Effective Interventions to Prevent Malaria and Anemia: What Program Managers and Policymakers Should Know.”  This brief was developed by USAID’s Maternal and Child Survival Program in collaboration with the President’s Malaria Initiative. 

To access these documents, please go to the Components of the Integrated Package Tab and then to either the Malaria Prevention and Control or Iron-Folic Acid Supplementation Sub-Tabs. Under each of these Sub-Tabs, you will find “Giving Folic Acid with IPTp” with information about the documents.  Both these places provide information and links to the Consensus Statement and Brief.  They also provide additional resources for IFA supplementation and malaria control, with studies that support the lower dose of folic acid. We suggest visiting both places as the information and resources are different in each place.